SLC5A5 and hepatocellular carcinoma: Non-viral delivery methods like mesenchymal-stem-cell- or extracellular-vesicle-mediated delivery of NIS transgene have shown effective radio-iodine treatment in pre-clinical breast or hepatocellular carcinoma models, respectively.3